Vicarious Surgical Inc RBOT.N reported a quarterly adjusted loss of $2.23 per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $-2.59. The mean expectation of three analysts for the quarter was for a loss of $2.50 per share. Wall Street expected results to range from $-2.61 to $-2.27 per share.
Reported revenue was zero; analysts expected zero.
Vicarious Surgical Inc's reported EPS for the quarter was a loss of $2.23.
The company reported a quarterly loss of $13.22 million.
Vicarious Surgical Inc shares had risen by 22.7% this quarter and lost 30.1% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts was unchanged in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Wall Street's median 12-month price target for Vicarious Surgical Inc is $10.75, about 14.4% above its last closing price of $9.20
This summary was machine generated from LSEG data August 12 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Jun. 30 2025 | -2.50 | -2.23 | Beat |
Mar. 31 2025 | -2.48 | -2.60 | Missed |
Dec. 31 2024 | -2.69 | -2.36 | Beat |
Sep. 30 2024 | -2.55 | -2.90 | Missed |